尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by White Marvin L, 董事长兼首席执行官. Insider active across 2 companies, notably Emergent BioSolutions Inc.. In total, 16 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €160k. Activity tracked since 20 May 2021. The latest transaction was disclosed on 6 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 条申报中的 16 条
White Marvin L is Président-Directeur Général, Administrateur. He is linked to Aptevo Therapeutics Inc. and Emergent BioSolutions Inc. The 13 filings cover the period from 2021-05-24 to 2025-07-21; within the sampled recent filings, total sell volume is EUR 159605 and the most common transaction nature is Levée d'options.